Beeks, VV;
Achilleos, S;
Quattrocchi, A;
Pallari, CT;
Critselis, E;
Salameh, P;
Rahmanian Haghighi, MR;
Rodriguez-Llanes, JM;
Ambrosio, G;
Artemiou, A;
et al.
Beeks, VV; Achilleos, S; Quattrocchi, A; Pallari, CT; Critselis, E; Salameh, P; Rahmanian Haghighi, MR; Rodriguez-Llanes, JM; Ambrosio, G; Artemiou, A; Gabel, J; Bennett, CM; Cuthbertson, J; Zimmermann, C; Schernhammer, ES; Costa, AJL; de Carvalho, LF; Lobato, JCP; Athanasiadou, M; Critchley, JA; Goldsmith, LP; Kandelaki, L; Glushkova, N; Davletov, K; Semenova, Y; Erzen, I; Verstiuk, O; Alekkou, D; Polemitis, A; Charalambous, A; Demetriou, CA; C-MOR Consortium
(2024)
Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020-2021) in 12 Countries of the C-MOR Consortium.
J Epidemiol Glob Health, 14 (2).
pp. 337-348.
ISSN 2210-6014
https://doi.org/10.1007/s44197-024-00242-4
SGUL Authors: Critchley, Julia Goldsmith, Lucy Pollyanna
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
|
![]() |
Microsoft Word (.docx) (Supplementary file 1)
Supplemental Material
Download (4MB) |
Abstract
BACKGROUND: This study investigated cause-specific mortality rates in 12 countries during the COVID-19 pandemic in 2020 and 2021. METHODS: We collected weekly cause-specific mortality data from respiratory disease, pneumonia, cardiovascular disease (CVD) and cancer from national vital statistic databases. We calculated excess mortality for respiratory disease (excluding COVID-19 codes), pneumonia, and CVD in 2020 and 2021 by comparing observed weekly against expected mortality based on historical data (2015-2019), accounting for seasonal trends. We used multilevel regression models to investigate the association between country-level pandemic-related variables and cause-specific mortality. RESULTS: Significant reductions in cumulative mortality from respiratory disease and pneumonia were observed in 2020 and/or 2021, except for Georgia, Northern Ireland, Kazakhstan, and Ukraine, which exhibited excess mortality for one or both causes. Australia, Austria, Cyprus, Georgia, and Northern Ireland experienced excess cumulative CVD mortality in 2020 and/or 2021. Australia, Austria, Brazil, Cyprus, Georgia, Northern Ireland, Scotland and Slovenia, experienced increased crude cumulative cancer mortality during 2020 and/or 2021 compared to previous years. Among pandemic-related variables, reported COVID-19 incidence was negatively associated with increased cancer mortality, excess respiratory, (2020) and pneumonia (2021) mortality, and positively associated with respiratory and CVD mortality (2021). Stringency of control measures were negatively associated with excess respiratory disease, CVD, and increased cancer mortality (2021). CONCLUSIONS: This study provides evidence of substantial excess mortality from CVD, and notable reductions in respiratory disease and pneumonia in both years across most countries investigated. Our study also highlights the beneficial impact of stringent control measures in mitigating excess mortality from most causes in 2021.
Item Type: | Article | ||||||||
---|---|---|---|---|---|---|---|---|---|
Additional Information: | © The Author(s) 2024 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | ||||||||
Keywords: | COVID-19, Cancer, Cardiovascular diseases, Cause-specific mortality, Public health measures, Respiratory tract infections, C-MOR Consortium, Cancer, Cardiovascular diseases, Cause-specific mortality, COVID-19, Public health measures, Respiratory tract infections, 1108 Medical Microbiology, 1117 Public Health and Health Services | ||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Population Health Research Institute (INPH) Academic Structure > REF 2021 user group |
||||||||
Journal or Publication Title: | J Epidemiol Glob Health | ||||||||
ISSN: | 2210-6014 | ||||||||
Language: | eng | ||||||||
Dates: |
|
||||||||
Publisher License: | Creative Commons: Attribution 4.0 | ||||||||
PubMed ID: | 38775902 | ||||||||
Go to PubMed abstract | |||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/116521 | ||||||||
Publisher's version: | https://doi.org/10.1007/s44197-024-00242-4 |
Statistics
Actions (login required)
![]() |
Edit Item |